Supplements

Comorbidities complicate multiple sclerosis management by exacerbating symptoms and influencing clinical decision-making

This qualitative pilot study found that comorbidities significantly complicate MS management, as reported by both individuals with MS and healthcare professionals. Participants emphasized the need for enhanced coordination between providers and more comprehensive, interdisciplinary care models.

Last updated: Jul 7, 2026โ€ข0 RCTsโ€ข๐Ÿ“– Read as article โ†’

Evidence Score

Evidence Score32/100
Human RCTโ˜†โ˜†โ˜†โ˜†โ˜†
Meta-analysisโ˜†โ˜†โ˜†โ˜†โ˜†
Mechanismโ˜†โ˜†โ˜†โ˜†โ˜†
Safetyโ˜†โ˜†โ˜†โ˜†โ˜†
Confidencelow

Study Evidence

Study 1. Bridging perspectives on comorbidities in multiple sclerosis: A pilot study with individuals with lived experience and healthcare professionals.

observational

Karim ME, Sage O, Thandi M, Frank HA, Marrie RA, Tremlett H, McKay K, Cox S, Lix L, Zhu F, Yusuf F ยท Multiple sclerosis and related disorders (2026)

Participants: N/A
Duration: Interviews conducted February 26 to March 15, 2024
Intervention: Qualitative semi-structured interviews exploring the impact of comorbidities on MS management
Outcome: Themes related to MS progression, treatment decisions, daily experiences, and need for integrated care
Effect Size: N/A
Population: 5 individuals living with MS and 5 healthcare professionals with experience treating MS

Result:

Mechanism Graph

Comorbidities are present in individuals with MS
โ†“
Comorbidities exacerbate MS symptoms
โ†“
Comorbidities influence clinical decision-making
โ†“
Result: Increased complexity in MS management

Limitations

  • โš Small sample size (n=10 total)
  • โš Qualitative design limits generalizability
  • โš No quantitative effect sizes reported

Products

Affiliate links coming soon. We only recommend products that match the doses and forms used in the cited research.

References

  1. 1.Karim ME, Sage O, Thandi M, Frank HA, Marrie RA, Tremlett H, McKay K, Cox S, Lix L, Zhu F, Yusuf F. "Bridging perspectives on comorbidities in multiple sclerosis: A pilot study with individuals with lived experience and healthcare professionals.." Multiple sclerosis and related disorders, 2026. PMID: 41830893 DOI: 10.1016/j.msard.2026.107127
Disclaimer: This content is for educational purposes only and is not medical advice. Evidence scores reflect the quality and quantity of available research, not clinical recommendations. Always consult a healthcare professional before starting any supplement or intervention.